“Variant of Kovid, New Challenge to Vaccines”

The end of December should be a happy time at the end of this long year of fighting the coronavirus. Europe authorized the marketing of the first vaccine against Kovid, which, fortunately, was very effective and without serious side effects. The hope is to get back to normal life as soon as possible. But the invention of a new variant of the virus spread like wildfire in the south of England and lasted until “Can transmit 70% more than the old” Throws a dark mask at the end of the year. Despite many uncertainties over the exact effect of these mutations – all other explanations for the recent re-emergence of the epidemic in London are possible – most countries in Europe have not hesitated to suspend relations with Great Britain.

Also read:We know about the latest SARS-CV-2 mutations

Isn’t the border lockdown too late? Is it enough to prevent the spread of this variant of the virus?